BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Schipper K, Seinstra D, Paulien Drenth A, van der Burg E, Ramovs V, Sonnenberg A, van Rheenen J, Nethe M, Jonkers J. Rebalancing of actomyosin contractility enables mammary tumor formation upon loss of E-cadherin. Nat Commun 2019;10:3800. [PMID: 31444332 DOI: 10.1038/s41467-019-11716-6] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 2.7] [Reference Citation Analysis]
Number Citing Articles
1 Schipper K, Drenth AP, van der Burg E, Cornelissen S, Klarenbeek S, Nethe M, Jonkers J. Truncated ASPP2 Drives Initiation and Progression of Invasive Lobular Carcinoma via Distinct Mechanisms. Cancer Res 2020;80:1486-97. [PMID: 32060147 DOI: 10.1158/0008-5472.CAN-19-3607] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
2 Nikolaou S, Machesky LM. The stressful tumour environment drives plasticity of cell migration programmes, contributing to metastasis. J Pathol 2020;250:612-23. [PMID: 32057095 DOI: 10.1002/path.5395] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
3 Graziani V, Rodriguez-Hernandez I, Maiques O, Sanz-Moreno V. The amoeboid state as part of the epithelial-to-mesenchymal transition programme. Trends Cell Biol 2021:S0962-8924(21)00206-3. [PMID: 34836782 DOI: 10.1016/j.tcb.2021.10.004] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 8.0] [Reference Citation Analysis]
4 Van Baelen K, Geukens T, Maetens M, Tjan – Heijnen V, Lord C, Linn S, Bidard F, Richard F, Yang W, Steele R, Pettitt S, Van Ongeval C, De Schepper M, Isnaldi E, Nevelsteen I, Smeets A, Punie K, Voorwerk L, Wildiers H, Floris G, Vincent-salomon A, Derksen P, Neven P, Senkus E, Sawyer E, Kok M, Desmedt C. Current and future diagnostic and treatment strategies for patients with invasive lobular breast cancer. Annals of Oncology 2022. [DOI: 10.1016/j.annonc.2022.05.006] [Reference Citation Analysis]
5 Sflomos G, Schipper K, Koorman T, Fitzpatrick A, Oesterreich S, Lee AV, Jonkers J, Brunton VG, Christgen M, Isacke C, Derksen PWB, Brisken C. Atlas of Lobular Breast Cancer Models: Challenges and Strategic Directions. Cancers (Basel) 2021;13:5396. [PMID: 34771558 DOI: 10.3390/cancers13215396] [Reference Citation Analysis]
6 Ganz HM, Buchmann B, Engelbrecht LK, Jesinghaus M, Eichelberger L, Gabka CJ, Schmidt GP, Muckenhuber A, Weichert W, Bausch AR, Scheel CH. Generation of ductal organoids from normal mammary luminal cells reveals invasive potential. J Pathol 2021. [PMID: 34467523 DOI: 10.1002/path.5790] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Sflomos G, Battista L, Aouad P, De Martino F, Scabia V, Stravodimou A, Ayyanan A, Ifticene-Treboux A, Bucher P, Fiche M, Ambrosini G, Brisken C; RLS. Intraductal xenografts show lobular carcinoma cells rely on their own extracellular matrix and LOXL1. EMBO Mol Med 2021;13:e13180. [PMID: 33616307 DOI: 10.15252/emmm.202013180] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
8 Devanny AJ, Vancura MB, Kaufman LJ. Exploiting differential effects of actomyosin contractility to control cell sorting among breast cancer cells. Mol Biol Cell 2021;32:ar24. [PMID: 34432511 DOI: 10.1091/mbc.E21-07-0357] [Reference Citation Analysis]
9 Nagai T, Ishikawa T, Minami Y, Nishita M. Tactics of cancer invasion: solitary and collective invasion. J Biochem 2020;167:347-55. [PMID: 31926018 DOI: 10.1093/jb/mvaa003] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 5.5] [Reference Citation Analysis]
10 Krimpenfort RA, Nethe M. Canonical Wnt: a safeguard and threat for erythropoiesis. Blood Adv 2021;5:3726-35. [PMID: 34516644 DOI: 10.1182/bloodadvances.2021004845] [Reference Citation Analysis]
11 Christgen M, Cserni G, Floris G, Marchio C, Djerroudi L, Kreipe H, Derksen PWB, Vincent-Salomon A. Lobular Breast Cancer: Histomorphology and Different Concepts of a Special Spectrum of Tumors. Cancers (Basel) 2021;13:3695. [PMID: 34359596 DOI: 10.3390/cancers13153695] [Reference Citation Analysis]
12 Monster JL, Kemp LJS, Gloerich M, van der Post RS. Diffuse gastric cancer: Emerging mechanisms of tumor initiation and progression. Biochim Biophys Acta Rev Cancer 2022;:188719. [PMID: 35307354 DOI: 10.1016/j.bbcan.2022.188719] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Peng LH, Wang MZ, Chu Y, Zhang L, Niu J, Shao HT, Yuan TJ, Jiang ZH, Gao JQ, Ning XH. Engineering bacterial outer membrane vesicles as transdermal nanoplatforms for photo-TRAIL-programmed therapy against melanoma. Sci Adv 2020;6:eaba2735. [PMID: 32923586 DOI: 10.1126/sciadv.aba2735] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 6.5] [Reference Citation Analysis]
14 Zheng L, Cao J, Liu L, Xu H, Chen L, Kang L, Gao L. Long noncoding RNA LINC00982 upregulates CTSF expression to inhibit gastric cancer progression via the transcription factor HEY1. Am J Physiol Gastrointest Liver Physiol 2021;320:G816-28. [PMID: 33236952 DOI: 10.1152/ajpgi.00209.2020] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]